SUPRACOR™ Advisor против IOL Reference Использование & Stats

With the B+L SUPRACOR™ Advisor app, you can get laser treatment recommendations according to various patient’s profiles. Ease your daily refractive workflow using SUPRACOR™! Start by selecting the visual condition that you want to treat. After, you will have to indicate: - Patient Expectation - Spherical equivalent (D) - Keratometry (D) Bausch + Lomb SUPRACOR™ Advisor app will provide you with generic treatment pathways: mild, regular and strong. The SUPRACOR™ Advisor is recommending options based on standard estimates only. The surgeon develops their own decision and is responsible for patient outcomes. Please note that any information provided is not a substitute for professional medical advice. This app is intended for use by Surgical Professionals or in conjunction with a Surgical Professional.
  • Apple App Store
  • Бесплатный
  • Медицина

Рейтинг магазина

- -

IOL Reference is a cross-platform ophthalmology utility, social media, and networking service that provides users with a wide array of eye care tools to optimize their outcomes. This unique app allows surgeons to quickly search for an FDA-approved, currently marketed intraocular lens (IOLs) that meets their needs and specifications. The database contains almost 10,000 individually cataloged lenses and will be updated to include newly FDA-approved IOLs, changes to current lenses, and corrections. This app was created by Gurpal Virdi, MD and Matt Hirabayashi, MD
  • Apple App Store
  • Бесплатный
  • Медицина

Рейтинг магазина

- -

SUPRACOR™ Advisor vs. IOL Reference ranking comparison

Compare SUPRACOR™ Advisor ranking trend in the past 28 days vs. IOL Reference

Rank

Нет данных

Рейтинг SUPRACOR™ Advisor против IOL Reference в сравнении по странам

Сравните динамику рейтинга SUPRACOR™ Advisor за последние 28 дней с динамикой рейтинга IOL Reference.

Нет данных для отображения

Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией

Начать
SUPRACOR™ Advisor VS.
IOL Reference

январь 12, 2025